Symbol
Allogene Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.36
Current price of the stock
$3M
Trading volume of the stock
$284.5M
Market capitalization of the company
Micro Cap
Category of market capitalization
23.70%
Long-term growth mean estimate
4.56
Mean analyst rating
585.15%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
9.35
Current ratio
-
Gross profit margin
-
Operating profit margin
-
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-
Pretax profit margin
-
Net profit margin
-14.30%
Measures profitability relative to shareholders' equity
-14.30%
ROE excluding intangible assets
-11.25%
Measures profitability relative to total assets
-14.30%
Measures profitability relative to invested capital
-
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.88
Measures valuation relative to earnings
-0.76
P/E based on future earnings estimates
6616.20
Measures valuation relative to sales
0.61
Measures valuation relative to book value
-0.42
Measures valuation relative to operating cash flow
-0.42
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
